News

Stay updated on our progress through our company highlights.

All
Announcements
Press Releases
In The News

June 16, 2026 | In The News
Integrated Nanotherapeutics is featured by Pacific Economic Development Canada (PacifiCan) with an exclusive interview with our CEO, Chris Tam.

June 10, 2026 | Announcement
Integrated Nanotherapeutics will be partnering at BIO International 2026, June 22-25, in San Diego, CA.

May 06, 2026 | Announcement
Integrated Nanotherapeutics will be exhibiting at Web Summit 2026, May 11-14, in Vancouver, BC.

Apr 20, 2026 | Announcement
Integrated Nanotherapeutics will be speaking at the 21st Immunology of Diabetes Society Congress & Australian Islet Study Group Meeting (IDS) 2026, Apr 20-24, in Brisbane, Australia.

Mar 18, 2026 | Press Release
Integrated Nanotherapeutics Secures Genome Canada GAPP Funding to Advance Multi-Cargo mRNA/LNP Therapy for Type 1 Diabetes Toward the Clinic.

Mar 03, 2026 | Announcement
Integrated Nanotherapeutics will be speaking at the 9th Antigen-Specific Immune Tolerance Summit (ASIT) 2026 Annual Meeting, Mar 3-6, in Boston.

June 18, 2026 | Announcement
Integrated Nanotherapeutics welcomes Dr. Carmella Evans-Molina to the Scientific Advisory Board.

June 22, 2026 | Announcement
Integrated Nanotherapeutics is invited to exhibit at World Health Expo (WHX) Osaka 2026, July 2-4, in Osaka, Japan.

Jan 12, 2026 | Announcement
Integrated Nanotherapeutics will be attending Biotech Showcase 2026 during JPM Week, Jan 13 – 15, in San Francisco.

Feb 25, 2025 | Announcement
Integrated Nanotherapeutics will be speaking at the 8th Antigen-Specific Immune Tolerance Summit (ASIT) 2025, Feb 25 – 27, in Boston.

Jan 15, 2025 | Announcement
Integrated Nanotherapeutics will be attending Biotech Showcase 2025 during JPM Week, Jan 13 – 15, in San Francisco.

Sep 09, 2024 | Press Release
Integrated Nanotherapeutics and Breakthrough T1D Collaborate to Advance Development of an Immune Tolerizing Therapeutic to Treat Type 1 Diabetes.

Jun 11, 2024 | Press Release
Integrated Nanotherapeutics is presenting T1D preclinical data at the Federation of Clinical Immunology Societies (FOCIS) 2024 Annual Meeting, June 18 – 21, in San Francisco.